Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-148497

Chief Development Officer sold 20,000 shares at $40.97 ($819,400)

  • Chief Development Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-07 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $21.65 $433,000 22,231 D
2026-04-07 Sale : show line 2 in the form 10b5-1 −20,000 $40.97 $819,400 2,231 D
Open-market sales · 20,000 sh · avg $40.97 · $819,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-07 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −20,000 190,000 D
Loading xslF345X06/ownership.xml…